Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study - Concepedia

Concepedia

Publication | Open Access

Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD study

DOI Full Paper Access

333

Citations

30

References

2008

Year

Roy Fleischmann, Jiří Vencovský, Ronald van Vollenhoven, David Borenstein, Jeffrey Box, G. Coteur, Niti Goel, H P Brezinschek, A Innes, Vibeke Strand

Annals of the Rheumatic Diseases

Abstract

NCT00548834.

References

	Year	Citations

Page 1